Last €2.04 EUR
Change Today +0.17 / 9.09%
Volume 119.8K
NEU On Other Exchanges
Symbol
Exchange
Continuous
Stuttgart
As of 8:03 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

neuron biopharma sa (NEU) Snapshot

Open
€1.88
Previous Close
€1.87
Day High
€2.05
Day Low
€1.88
52 Week High
03/31/14 - €4.16
52 Week Low
10/30/14 - €0.64
Market Cap
14.2M
Average Volume 10 Days
86.0K
EPS TTM
€-0.25
Shares Outstanding
6.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEURON BIOPHARMA SA (NEU)

Related News

No related news articles were found.

neuron biopharma sa (NEU) Related Businessweek News

No Related Businessweek News Found

neuron biopharma sa (NEU) Details

Neuron BioPharma, S.A. discovers and develops compounds to prevent or treat various neurodegenerative diseases. The company focuses its research on the Alzheimer’s disease. Neuron BioPharma, S.A. was founded in 2005 and is based in Granada, Spain.

Founded in 2005

neuron biopharma sa (NEU) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

neuron biopharma sa (NEU) Key Developments

Neuron Biopharma, S.A. Presents at 10th Foro MedCap, May-27-2014

Neuron Biopharma, S.A. Presents at 10th Foro MedCap, May-27-2014 . Venue: Palacio de la Bolsa, Plaza de la Lealtad, 1, 28014 Madrid, Spain.

Neuron Biopharma, S.A. Auditor Raises 'Going Concern' Doubt

Neuron Biopharma, S.A. filed its Annual on Apr 24, 2014 for the period ending Dec 31, 2013. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Neuron Biopharma, S.A. Auditor Raises 'Going Concern' Doubt

Neuron Biopharma, S.A. filed its Annual on Apr 30, 2013 for the period ending Dec 31, 2012. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEU:SM €2.04 EUR +0.17

NEU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEU.
View Industry Companies
 

Industry Analysis

NEU

Industry Average

Valuation NEU Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 11.6x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEURON BIOPHARMA SA, please visit www.neuronbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.